Nippon Shinyaku : Vyxeos® Combination for I.V. Injectio

NEWS RELEASE


March 26, 2024


Vyxeos® Combination for I.V. Injection Receives Approval for the Treatment of


High-risk...

Related Keywords

Japan , United States , Ireland , Dublin , Kyoto , Japanese , Toru Nakai , Brucec Cozadd , Japanese Society Of Hematology , Nippon Shinyaku Co Ltd , Jazz Pharmaceuticals , Corporate Communications Dept , Kanehara Co Ltd , Ministry Of Health , Receives Approval , Nippon Shinyaku , Practical Guidelines , Hematological Malignancies , Therapeutic Resistance , Acute Myeloid , Intj Mol , Conventional Cytarabine Plus Daunorubicin , Older Patients , Newly Diagnosed Secondary Acute Myeloid , Communications Dept , Markets ,